메뉴 건너뛰기




Volumn 14, Issue 1, 2000, Pages 135-145

Erythropoietin test methods

Author keywords

Athletes; Detection; Doping; Erythropoietin (EPO); Recombinant human erythropoietin (rhEPO)

Indexed keywords

FERRITIN; FIBRIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

EID: 0033930866     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2000.0059     Document Type: Article
Times cited : (22)

References (33)
  • 1
    • 0032941959 scopus 로고    scopus 로고
    • Effects of erythropoietin administration in training athletes and possible indirect detection in doping control
    • Audran M, Gareau R, Matecki S. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Medicine and Science of Sports and Exercise. 31:1999;639-645.
    • (1999) Medicine and Science of Sports and Exercise , vol.31 , pp. 639-645
    • Audran, M.1    Gareau, R.2    Matecki, S.3
  • 2
    • 0033007019 scopus 로고    scopus 로고
    • Peptide hormones abuse in sport: State of the art in the detection of growth hormone and erythropoietin
    • Rivier R, Saugy M. Peptide hormones abuse in sport: state of the art in the detection of growth hormone and erythropoietin. Journal of Toxicology and Toxin Reviews. 18:1999;145-176.
    • (1999) Journal of Toxicology and Toxin Reviews , vol.18 , pp. 145-176
    • Rivier, R.1    Saugy, M.2
  • 3
    • 0343891640 scopus 로고
    • Growth factors and control of haematopoiesis
    • R. Hoffmann, E. Benz, S. Shattil, B. Furie, & H. Cohen. New York: Churchill Livingstone
    • Bagby G, Segal G. Growth factors and control of haematopoiesis. Hoffmann R, Benz E, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 1991;97-121 Churchill Livingstone, New York.
    • (1991) Hematology: Basic Principles and Practice , pp. 97-121
    • Bagby, G.1    Segal, G.2
  • 4
    • 0343455905 scopus 로고
    • Pharmacologic alternatives to blood transfusion
    • R. Hoffmann, E. Benz, S. Shattil, B. Furie, & H. Cohen. New York: Churchill Livingstone
    • Goodnough L. Pharmacologic alternatives to blood transfusion. Hoffmann R, Benz E, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 1991;1665-1669 Churchill Livingstone, New York.
    • (1991) Hematology: Basic Principles and Practice , pp. 1665-1669
    • Goodnough, L.1
  • 5
    • 0022484262 scopus 로고
    • Characterization and biological effects of recombinant human erythropoietin
    • Egrie J C, Strickland T W, Lane J. Characterization and biological effects of recombinant human erythropoietin. Immunobiology. 172:1986;213-224.
    • (1986) Immunobiology , vol.172 , pp. 213-224
    • Egrie, J.C.1    Strickland, T.W.2    Lane, J.3
  • 6
    • 0028346320 scopus 로고
    • Erythropoietin stimulates immature reticulocyte release in man
    • Major A, Bauer C, Breymann C. Erythropoietin stimulates immature reticulocyte release in man. British Journal of Haematology. 87:1994;605-608.
    • (1994) British Journal of Haematology , vol.87 , pp. 605-608
    • Major, A.1    Bauer, C.2    Breymann, C.3
  • 7
    • 0026512123 scopus 로고
    • Detection of functional iron deficiency during erythropoietin treatment: A new approach
    • McDougall I C, Cavill I, Hulme B. Detection of functional iron deficiency during erythropoietin treatment: a new approach. British Medical Journal. 304:1992;225-226.
    • (1992) British Medical Journal , vol.304 , pp. 225-226
    • McDougall, I.C.1    Cavill, I.2    Hulme, B.3
  • 8
    • 0028438939 scopus 로고
    • Effects of subcutaneous recombinant human erythropoietin in normal subjects: Development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis
    • Brugnara C, Colella G M, Cremins J. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. Journal of Laboratory and Clinical Medicine. 123:1994;660-667.
    • (1994) Journal of Laboratory and Clinical Medicine , vol.123 , pp. 660-667
    • Brugnara, C.1    Colella, G.M.2    Cremins, J.3
  • 9
    • 0030071458 scopus 로고    scopus 로고
    • Optimal timing of repeated recombinant human erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers
    • Breymann C, Bauer C, Major A. Optimal timing of repeated recombinant human erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. British Journal of Haematology. 92:1996;295-301.
    • (1996) British Journal of Haematology , vol.92 , pp. 295-301
    • Breymann, C.1    Bauer, C.2    Major, A.3
  • 11
    • 0019992506 scopus 로고
    • Diurnal variation of serum immunoreactive erythropoietin in a normal subject
    • Cotes P M, Brozovic B. Diurnal variation of serum immunoreactive erythropoietin in a normal subject. Clinical Endocrinology. 17:1982;419-422.
    • (1982) Clinical Endocrinology , vol.17 , pp. 419-422
    • Cotes, P.M.1    Brozovic, B.2
  • 12
    • 0025967383 scopus 로고
    • Bestimmung der Erythropoietin-Aktivät im Serum. Methodik, Indikation und Interpretation der Messdaten
    • Jelkmann W, Wolff M. Bestimmung der Erythropoietin-Aktivät im Serum. Methodik, Indikation und Interpretation der Messdaten. Deutsche Medizinische Wochenschrift. 116:1991;230-234.
    • (1991) Deutsche Medizinische Wochenschrift , vol.116 , pp. 230-234
    • Jelkmann, W.1    Wolff, M.2
  • 13
    • 0343020305 scopus 로고
    • Erythrocytosis
    • R. Hoffmann, R. Benz, S. Shattil, B. Furie, & H. Cohen. New York: Churchill Livingstone
    • Spivak J. Erythrocytosis. Hoffmann R, Benz R, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 1991;319-326 Churchill Livingstone, New York.
    • (1991) Hematology: Basic Principles and Practice , pp. 319-326
    • Spivak, J.1
  • 14
    • 0023911237 scopus 로고
    • The heterogeneity of circulating human serum erythropoietin
    • Sherwood J B, Carmichael L D, Goldwasser E. The heterogeneity of circulating human serum erythropoietin. Endocrinology. 122:1988;1472-1477.
    • (1988) Endocrinology , vol.122 , pp. 1472-1477
    • Sherwood, J.B.1    Carmichael, L.D.2    Goldwasser, E.3
  • 15
    • 0028401651 scopus 로고
    • The molecular physiology of erythropoietin and the erythropoietin receptor
    • Zhu Y, D'Andrea A D. The molecular physiology of erythropoietin and the erythropoietin receptor. Current Opinion in Hematology. 1:1994;113-118.
    • (1994) Current Opinion in Hematology , vol.1 , pp. 113-118
    • Zhu, Y.1    D'Andrea, A.D.2
  • 17
    • 0028859515 scopus 로고
    • Application of a modified INCSTAR EPO-trac 125/RIA for measurement of serum erythropoietin concentration in elite athletes
    • Roberts D, Schuh D, Smith D J. Application of a modified INCSTAR EPO-trac 125/RIA for measurement of serum erythropoietin concentration in elite athletes. Clinical Biochemistry. 28:1995;573-580.
    • (1995) Clinical Biochemistry , vol.28 , pp. 573-580
    • Roberts, D.1    Schuh, D.2    Smith, D.J.3
  • 19
    • 0029813724 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control
    • Souillard A, Audran M, Bressolle F. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control. British Journal of Clinical Pharmacology. 42:1996;355-364.
    • (1996) British Journal of Clinical Pharmacology , vol.42 , pp. 355-364
    • Souillard, A.1    Audran, M.2    Bressolle, F.3
  • 20
    • 0025123840 scopus 로고
    • Molecular charge heterogeneity of human serum EPO
    • Wide L, Bengtsson C. Molecular charge heterogeneity of human serum EPO. British Journal of Haematology. 76:1990;121-127.
    • (1990) British Journal of Haematology , vol.76 , pp. 121-127
    • Wide, L.1    Bengtsson, C.2
  • 22
    • 0032576401 scopus 로고    scopus 로고
    • What is a normal red-blood cell mass for professional cyclists?
    • Saris W, Senden J, Brouns F. What is a normal red-blood cell mass for professional cyclists? Lancet. 352:1998;1758.
    • (1998) Lancet , vol.352 , pp. 1758
    • Saris, W.1    Senden, J.2    Brouns, F.3
  • 23
    • 0032497140 scopus 로고    scopus 로고
    • Packed cell volume in elite athletes
    • Marx J J, Vergouwen P C. Packed cell volume in elite athletes. Lancet. 352:1998;451.
    • (1998) Lancet , vol.352 , pp. 451
    • Marx, J.J.1    Vergouwen, P.C.2
  • 24
    • 0033007485 scopus 로고    scopus 로고
    • Erythropoietin concentration and arterial haemoglobin saturation with supramaximal exercise
    • Roberts D, Smith D J. Erythropoietin concentration and arterial haemoglobin saturation with supramaximal exercise. Journal of Sports Sciences. 17:1999;485-493.
    • (1999) Journal of Sports Sciences , vol.17 , pp. 485-493
    • Roberts, D.1    Smith, D.J.2
  • 27
    • 0034071563 scopus 로고    scopus 로고
    • 'Blood doping' with rhEPO and assessment of functional iron deficiency in healthy volunteers
    • Breymann C, Rohling R, Krafft A. 'Blood doping' with rhEPO and assessment of functional iron deficiency in healthy volunteers. British Journal of Haematology. 108:2000;883.
    • (2000) British Journal of Haematology , vol.108 , pp. 883
    • Breymann, C.1    Rohling, R.2    Krafft, A.3
  • 28
    • 0030825066 scopus 로고    scopus 로고
    • Population pharmacodynamics for monitoring epoietin abuse in athletes
    • Bressolle F, Audran M, Guidicelli C. Population pharmacodynamics for monitoring epoietin abuse in athletes. Clinical Drug Investigation. 14:1997;233-242.
    • (1997) Clinical Drug Investigation , vol.14 , pp. 233-242
    • Bressolle, F.1    Audran, M.2    Guidicelli, C.3
  • 30
    • 0029928182 scopus 로고    scopus 로고
    • Erythropoietin abuse in athletes
    • Gareau R, Audran M, Baynes R D. Erythropoietin abuse in athletes. Nature. 380:1996;113.
    • (1996) Nature , vol.380 , pp. 113
    • Gareau, R.1    Audran, M.2    Baynes, R.D.3
  • 31
    • 0031442094 scopus 로고    scopus 로고
    • Comparison of a direct and indirect population pharmacodynamic model: Application to recombinant human erythropoietin in athletes
    • Bressolle F, Audran M, Gareau R. Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes. Journal of Pharmacokinetics and Biopharmaceutics. 25:1997;263-275.
    • (1997) Journal of Pharmacokinetics and Biopharmaceutics , vol.25 , pp. 263-275
    • Bressolle, F.1    Audran, M.2    Gareau, R.3
  • 32
    • 0029131778 scopus 로고
    • Total fibrin and fibrinogen degradation products in urine: A possible probe to detect illicit users of the physical-performance enhancer erythropoietin?
    • Gareau R, Brisson G R, Chenard C. Total fibrin and fibrinogen degradation products in urine: a possible probe to detect illicit users of the physical-performance enhancer erythropoietin? Hormone Research. 44:1995;189-192.
    • (1995) Hormone Research , vol.44 , pp. 189-192
    • Gareau, R.1    Brisson, G.R.2    Chenard, C.3
  • 33
    • 0032994109 scopus 로고    scopus 로고
    • Effects of iron supplementation on total body hemoglobin during endurance training at moderate altitude
    • Friedmann B, Jost J, Rating T. Effects of iron supplementation on total body hemoglobin during endurance training at moderate altitude. International Journal of Sports Medicine. 20:1999;78-85.
    • (1999) International Journal of Sports Medicine , vol.20 , pp. 78-85
    • Friedmann, B.1    Jost, J.2    Rating, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.